Navigation Links
MicroRNA regulation of tumor-killing viruses avoids unwanted viral pathology
Date:5/21/2009

Scientists have determined how to produce replication-competent viruses with key toxicities removed, providing a new platform for development of improved cancer treatments and better vaccines for a broad range of viral diseases.

Cellular microRNA molecules regulate the stability of mRNA in different cell types, and this newly-understood mechanism provides the possibility to engineer viruses for cell-specific inactivation. Cancer Research UK scientists at the University of Oxford, United Kingdom, with support from colleagues at Vrije Universiteit, Amsterdam, report that this approach can be used to regulate proliferation of adenovirus in a study published May 22 in the open-access journal PLoS Pathogens.

Adenovirus is a DNA virus widely used in cancer therapy but which causes hepatic disease in mice. Professor Len Seymour and colleagues found that introducing sites into the virus genome that are recognized by microRNA 122 leads to hepatic degradation of important viral mRNA, thereby diminishing the virus' ability to adversely affect the liver, while maintaining its ability to replicate in and kill tumor cells.

Tumor-killing replicating viruses are a hot topic in the biotherapeutics arena, with many clinical trials ongoing worldwide. That Professor Seymour's group set out to and has now defined a mechanism whereby wild type virus potency could be maintained in tumor cells but the virus could be 'turned off' in tissues vulnerable to pathology adds important information to the current base of knowledge.

"This approach is surprisingly effective and quite versatile. It could find a range of applications in controlling the activity of therapeutic viruses, both for cancer research and also to engineer a new generation of conditionally-replicating vaccines, where the vaccine pathogen is disabled in its primary sites of toxicity," Professor Seymour says.

The present study was intended mainly to explore and demonstrate the potential of this new mechanism to regulate virus activity. Although the current tumor-killing virus is useful in mice, transfer of the technology into the clinical setting will require re-engineering of the virus to overcome virus pathologies seen in humans, and it will be at least two years before this can be tested in the clinics.


'/>"/>

Contact: Emma Gilgunn-Jones
emma.gilgunn-jones@cancer.org.uk
44-207-061-8311
Public Library of Science
Source:Eurekalert

Related medicine news :

1. Exiqon Announces New Grant Program for MicroRNA Research
2. Throwing the micro switch: MicroRNA may link smoking risk gene to neurobiology of addiction
3. InteRNA Technologies and Radboud University Nijmegen Medical Centre to Develop microRNA-based Therapeutics for Prostate Cancer
4. MicroRNA undermines tumor suppression
5. MicroRNAs make for safer cancer treatments
6. Gladstone scientists identify single microRNA that controls blood vessel development
7. Putting microRNAs on the stem cell map
8. Need microRNA processing? Get Smad
9. MicroRNA controls expression of oncogenes
10. MicroRNAs appear essential for retinal health
11. MicroRNAs, EMT and cancer progression
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2016)... ... May 23, 2016 , ... Four Circles Recovery Center, a leading treatment center ... announce the launch of its new extended care program, Fifth Circle. Available for clients ... Circles or another primary treatment program, Fifth Circle is designed to foster the recovery ...
(Date:5/23/2016)... ... 23, 2016 , ... Bio-Optronics, Inc. is delighted to announce ... its recent and anticipated growth. , Max Elbaz was appointed as Vice President, ... segments. Max joined the Bio-Optronics team in March. His areas of expertise include ...
(Date:5/23/2016)... Plano, TX (PRWEB) , ... May 23, 2016 , ... ... Analytics’ on June 10, 2016 from 11:00 AM – 12:00 PM ET. To ... GlobalHealth’s decision to start a proactive outreach program built on Big Data with a ...
(Date:5/23/2016)... ... , ... Celebrating their 20th anniversary this year, Metcal Technologies ... MadgeTech data loggers. These qualifications translate to excellent customer service for the life ... and valued distributors. , Metcal is now offering the RFC1000 Cloud Relay ...
(Date:5/23/2016)... ... ... announced today the upcoming airing of Innovations with Ed ... 2016 at 4:00pET via Fox Business. , The show ... innovation to safely and rapidly develop cures for mosquito-borne, ...
Breaking Medicine News(10 mins):
(Date:5/23/2016)... , May 23, 2016   Purdue ... entered into an agreement with Egalet Corporation and ... claims. As part of the agreement the companies ... will enable all three companies to develop and ... "This agreement reflects the commitment of ...
(Date:5/20/2016)... 20, 2016 ReportsnReports.com adds ... Medical Devices of its online business intelligence library. ... the current state of the Titrator industry. The ... like definitions, classifications, Specifications, applications and industry chain ... like Raw Material Suppliers, Equipment Suppliers, Manufacturing Cost ...
(Date:5/20/2016)... LONDON , May 20, 2016 ... for Therapeutic Antibody Technologies, Insulins, Growth Hormones, Recombinant ... Emerging Biological Drugs - This New Study Reveals ... Stay Ahead ,What is the ... get the latest technological and commercial analysis. Staying ...
Breaking Medicine Technology: